advertisement

---

Journal of Ocular Pharmacology and Therapeutics 11

Showing records 1 to 11 | Display all abstracts in Journal of Ocular Pharmacology and Therapeutics

8425 Intraocular pressure fluctuations in medical versus surgically treated glaucomatous patients
Medeiros FA; Pinheiro A; Moura FC; Leal BC; Susanna R Jr
Journal of Ocular Pharmacology and Therapeutics 2002; 18: 489-498

---

8633 Conjunctival hyperemia and the use of topical prostaglandins in glaucoma and ocular hypertension
Feldman RM
Journal of Ocular Pharmacology and Therapeutics 2003; 19: 23-35

---

8505 Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor
Sharif NA; Kelly CR; Crider JY
Journal of Ocular Pharmacology and Therapeutics 2002; 18: 313-324

---

8648 Amelioration by topical bunazosin hydrochloride of the impairment in ocular blood flow caused by nitric oxide synthase inhibition in rabbits
Goto W; Oku H; Okuno T; Sugiyama T; Ikeda T
Journal of Ocular Pharmacology and Therapeutics 2003; 19: 63-73

---

8553 Postoperative subconjunctival mitomycin-C injection after non-penetrating glaucoma surgery
Iester M; Ravinet E; Mermoud A
Journal of Ocular Pharmacology and Therapeutics 2002; 18: 307-312

---

8567 Ocular hypotension induced by electroacupuncture
Chu TC; Potter DE
Journal of Ocular Pharmacology and Therapeutics 2002; 18: 293-305

---

8417 Effect of different dose schedules of bimatoprost on intraocular pressure and pupil size in the glaucomatous beagle
Gelatt KN; MacKay EO
Journal of Ocular Pharmacology and Therapeutics 2002; 18: 525-534

---

8812 A prospective, long-term, randomized study of the efficacy and safety of the drug combination pilocarpine 1% with clonidine 0.06% or clonidine 0.125% versus timolol 0.25%
Sihota R; Rajashekhar YL; Venkatesh P; Agarwal H
Journal of Ocular Pharmacology and Therapeutics 2002; 18: 499-506

---

8754 A 3-month comparison of efficacy and safety of brimonidine-Purite 0.15% and brimonidine 0.2% in patients with glaucoma or ocular hypertension
Mundorf T; Williams R; Whitcup S; Felix C; Batoosingh A
Journal of Ocular Pharmacology and Therapeutics 2003; 19: 37-44

---

8641 Effects of kallidinogenase on ocular tissue circulation in rabbits
Fukaya Y; Tamaki Y; Tomidokoro A; Araie M
Journal of Ocular Pharmacology and Therapeutics 2002; 18: 515-524

---

8616 Biodegradable calcium phosphate nanoparticles as a new vehicle for delivery of a potential ocular hypotensive agent
Chu TC; He Q; Potter DE
Journal of Ocular Pharmacology and Therapeutics 2002; 18: 507-514

---